Lipodystrophy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
IONS | F | Ionis Pharmaceuticals, Inc. | -2.60 | |
BMY | F | Bristol-Myers Squibb Company | 0.66 |
Related Industries: Biotechnology Drug Manufacturers - Major
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
FTXH | C | First Trust Nasdaq Pharmaceuticals ETF | 7.16 | |
MEDX | F | Horizon Kinetics Medical ETF | 5.43 | |
WBIY | D | WBI Power Factor High Dividend ETF | 4.72 | |
ARKG | D | ARK Genomic Revolution Multi-Sector ETF | 4.52 | |
PPH | C | Market Vectors Pharmaceutical ETF | 4.25 |
Compare ETFs
- Lipodystrophy
Lipodystrophy syndromes are a group of genetic or acquired disorders in which the body is unable to produce and maintain healthy fat tissue. The medical condition is characterized by abnormal or degenerative conditions of the body's adipose tissue. ("Lipo" is Greek for "fat", and "dystrophy" is Greek for "abnormal or degenerative condition".) A more specific term, lipoatrophy, is used when describing the loss of fat from one area (usually the face). This condition is also characterized by a lack of circulating leptin which may lead to osteosclerosis. The absence of fat tissue is associated with insulin resistance, hypertriglyceridemia, non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome.
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles